In April 2018, leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups and the FDA are convening to deliver on the promise of patient-centric clinical research and healthcare.
Bridging Clinical Research & Clinical Health Care Collaborative brings together industry leaders from Pharma, biotech, clinical research organizations, health care organizations, advocacy groups and the FDA to actualize a solution to increase patient and physician participation in clinical trials.
Keynote speakers include Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, and T.J. Sharpe, cancer survivor and patient advocate. Additional speakers and panelists will hold sessions on Bridging Regulatory, Bridging Technology, and Bridging People and Processes.
Review the full agenda or meet the speakers. To learn more, please visit https://www.bridgingclinical.com/about/
Bridging Clinical Research & Clinical Health Care Collaborative
April 4-5, 2018
Gaylord National Resort and Conference Center
National Harbor, MD
